Biocept, Inc.

BIOC · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$12,897$28,864$14,368$9,301
Short-Term Investments$0$0$0$0
Receivables$2,151$13,786$14,145$3,527
Inventory$757$2,651$1,930$768
Other Curr. Assets$538$391$2,152$296
Total Curr. Assets$16,343$45,692$32,594$13,893
Property Plant & Equip (Net)$14,144$14,269$14,432$3,840
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$386$456$426-$3,840
Total NC Assets$14,530$14,725$14,858$3,840
Other Assets$0$0$0$0
Total Assets$30,873$60,417$47,452$17,733
Liabilities
Payables$1,523$7,246$8,365$2,012
Short-Term Debt$1,734$1,509$964$1,567
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$2,249$3,018$3,166$1,980
Total Curr. Liab.$5,506$11,773$12,494$5,559
LT Debt$10,375$11,164$11,265$973
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$6,132$0$0$0
Total NC Liab.$16,507$11,164$11,265$973
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$22,013$22,937$23,759$6,532
Equity
Pref Stock$0$0$0$0
Common Stock$2$2$1$5
Retained Earnings-$298,438-$266,351-$263,527-$245,717
AOCI$0$0$0$0
Other Equity$307,296$303,829$287,218$256,912
Total Equity$8,860$37,480$23,692$11,201
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$30,873$60,417$47,452$17,733
Net Debt-$788-$16,191-$2,139-$6,761